Cytarabine
Who holds supplier records for Cytarabine? 7 organisations hold a current record for Cytarabine: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Italy (1) and India (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cytarabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cytarabine
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cytarabine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ARCHIMICA SPAItalyCEP Company GMP cert on recordActive DMF 25267 · latest filing Sept 2011
- ASAHI KASEI FINECHEM CO LTDCEPActive DMF 6215 · latest filing Jan 1986
- Fujian South Pharmaceutical Co. Ltd.ChinaActive DMF 41778 · latest filing Apr 2025
- SUZHOU YIFAN PHARMACEUTICAL CO LTDActive DMF 43089 · latest filing Nov 2025
- Zhejiang Hisun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 15959 · latest filing Apr 2002
- MAC CHEM PRODUCTS INDIA PVT LTDCEPInactive DMF 26281 · latest filing May 2012
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Cytarabine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ASAHI KASEI FINECHEM CO., LTD. Osaka | JP | CEP 2017-218 - Rev 04 Cytarabine | May 2026 | — |
| SAKAR HEALTHCARE LIMITED Ahmedabad | IN | CEP 2025-029 - Rev 00 Cytarabine | Mar 2026 | — |
| MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai | IN | CEP 2012-251 - Rev 03 Cytarabine | Jan 2026 | — |
| ARCHIMICA S.P.A Lodi | IT | CEP 2023-289 - Rev 00 Cytarabine, Process 2 | Feb 2024 | Inspected Feb 2026 Italy |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Cytarabine are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- CHANGZHOU AHK TECH INCInactive DMF 23469 · filed Jan 2010
- AXITEC CO LTDInactive DMF 18071 · filed Jan 2005
- United States · Inactive DMF 16896 · filed Oct 2003
- FARMOS GROUP LTD MEDIPOLARInactive DMF 7544 · filed Jun 1988
- APOTEX PHARMACHEM INCInactive DMF 7364 · filed Mar 1988
- ORCHIMIE SA (PRODUITS CHIMIQUES ET BIOCHIMIQUES)Inactive DMF 6668 · filed Nov 1986
- HEINRICH MACK NACHFInactive DMF 5311 · filed Mar 1984
- United States · Inactive DMF 1534 · filed Jun 1970
Overview
Cytarabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL803).
Chemical identity
- IUPAC name
- 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
- Canonical SMILES
- C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
- InChIKey
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N
- Synonyms
- Alexan, Alexan 100, Arabinocytosine, Arabinosyl cytosine, Ara-c, Ara-cytidine, Aracytidine, Aracytin, Aracytine, Citarabina, Cytarabine, Cytarabine component of vyxeos
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Metabolic Inhibitor
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cytarabine?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cytarabine: ARCHIMICA SPA (Italy), ASAHI KASEI FINECHEM CO LTD, Fujian South Pharmaceutical Co. Ltd. (China), SUZHOU YIFAN PHARMACEUTICAL CO LTD, Zhejiang Hisun Pharmaceutical Co., Ltd. (China), MAC CHEM PRODUCTS INDIA PVT LTD and Sakar Healthcare (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cytarabine Drug Master Files are active?
ARCHIMICA SPA (DMF 25267), ASAHI KASEI FINECHEM CO LTD (DMF 6215), Fujian South Pharmaceutical Co. Ltd. (DMF 41778), SUZHOU YIFAN PHARMACEUTICAL CO LTD (DMF 43089) and Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 15959). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cytarabine records mean?
8 organisations have only inactive Type II DMFs for Cytarabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cytarabine have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Cytarabine on the EDQM register, including ASAHI KASEI FINECHEM CO., LTD. Osaka (JP), SAKAR HEALTHCARE LIMITED Ahmedabad (IN), MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai (IN) and ARCHIMICA S.P.A Lodi (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Cytarabine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cytarabine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.